Hypochondriasis and obsessive-compulsive disorder in schizophrenic patients treated with clozapine vs other atypical antipsychotics

CNS Spectrums

Volumn 19, Issue 4, 2014, Pages 340-346

  Grassi, Giacomo ^a   Poli, Lorenzo ^a   Cantisani, Andrea ^a   Righi, Lorenzo ^b   Ferrari, Gabriella ^a   Pallanti, Stefano ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Atypical antipsychotics; clozapine; health anxiety; hypochondriasis; obsessive compulsive disorder; schizophrenia

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CITALOPRAM; CLOMIPRAMINE; CLOZAPINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; OLANZAPINE; PALIPERIDONE; PAROXETINE; QUETIAPINE; RISPERIDONE; SERTRALINE; VENLAFAXINE; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; SULPIRIDE; SULTOPRIDE;

ADULT; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLOBAL ASSESSMENT OF FUNCTIONING; HAMILTON SCALE; HUMAN; HYPOCHONDRIASIS; MAJOR CLINICAL STUDY; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OBSESSIVE COMPULSIVE DISORDER; POSITIVE AND NEGATIVE SYNDROME SCALE; PREVALENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; TREATMENT DURATION; YALE BROWN OBSESSIVE COMPULSIVE SCALE; ANALOGS AND DERIVATIVES; COMPARATIVE STUDY; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PSYCHOLOGY;

ADULT; ANTIPSYCHOTIC AGENTS; ARIPIPRAZOLE; BENZODIAZEPINES; CLOZAPINE; COMORBIDITY; FEMALE; HUMANS; HYPOCHONDRIASIS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PALIPERIDONE PALMITATE; PREVALENCE; QUETIAPINE FUMARATE; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SULPIRIDE;

EID: 84906556082     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852913000795     Document Type: Article

References (43)

1. Achim AM, Maziade M, Raymond E, et al. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull. 2011; 37(4): 811-821.
2. Tranulis C, Potvin S, Gourgue M, et al. The paradox of quetiapine in obsessive-compulsive disorder. CNS Spectr. 2005; 10(5): 356-361. (Pubitemid 41001887)
3. Schirmbeck F, Zink M. Clozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical review. Curr Neuropharmacol. 2012; 10(1): 88-95.
4. Cunill R, Castells X, Simeon D. Relationship between obsessivecompulsive symptomatology and severity of psychosis in schizophrenia: a systematic review and meta-analysis. J Clin Psychiatry. 2009; 70(1): 70-82.
5. Mukhopadhaya K, Krishnaiah R, Taye T, et al. Obsessivecompulsive disorder in UK clozapine-treated schizophrenia and schizoaffective disorder: a cause of clinical concern. J Psychopharmacol. 2009; 23(1): 6-13.
6. Sterk B, Lankreijer K, Linszen DH, de Haan L. Obsessivecompulsive symptoms in first episode psychosis and in subjects at ultra high risk for developing psychosis: onset and relationship to psychotic symptoms. Aust N Z J Psychiatry. 2011; 45(5): 400-405.
7. Zink M, Knopf U, Kuwilsky A. Management of clozapine-induced obsessive-compulsive symptoms in a man with schizophrenia. Aust N Z J Psychiatry. 2007; 41(3): 293-294. (Pubitemid 46705746)
8. Lim M, Park DY, Kwon JS, Joo YH, Hong KS. Prevalence and clinical characteristics of obsessive-compulsive symptoms associated with atypical antipsychotics. J Clin Psychopharmacol. 2007; 27(6): 712-713. (Pubitemid 351339464)
9. deHaan L, Sterk B, Wouters L, Linszen DH. The 5-years course of obsessive-compulsive symptoms and obsessive-compulsive disorder in first-episode schizophrenia and related disorders. Schizophr Bull. 2013; 39(1): 151-160.
10. Hwang MY, Kim SW, Yum SY, Opler LA. Management of schizophrenia with obsessive-compulsive features. Psychiatr Clin North Am. 2009; 32(4): 835-851.
11. Lykouras L, Alevizos B, Michalopoulou P, Rabavilas A. Obsessivecompulsive symptoms induced by atypical antipsychotics: a review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry. 2003; 27(3): 333-346. (Pubitemid 36403724)
12. Alevizos B, Papageorgiou C, Christodoulou GN. Obsessivecompulsive symptoms with olanzapine. Int J Neuropsychopharmacol. 2004; 7(3): 375-377.
13. Ke CL, Yen CF, Chen CC, et al. Obsessive-compulsive symptoms associated with clozapine and risperidone treatment: three case reports and review of the literature. Kaohsiung J Med Sci. 2004; 20(6): 295-301.
14. Ozer S, Arsava M, Ertugrul A, Demir B. Obsessive compulsive symptoms associated with quetiapine treatment in a schizophrenic patient: a case report. Prog Neuropsychopharmacol Biol Psychiatry. 2006; 30(4): 724-727. (Pubitemid 43732331)
15. Stamouli S, Lykouras L. Quetiapine-induced obsessive-compulsive symptoms: a series of five cases. J Clin Psychopharmacol. 2006; 26(4): 396-400. (Pubitemid 44187642)
16. Baker RW, Chengappa KN, Baird JW, et al. Emergence of obsessive compulsive symptoms during treatment with clozapine. J Clin Psychiatry. 1992; 53(12): 439-442. (Pubitemid 23018087)
17. deHaan L, Linszen DH, Gorsira R. Clozapine and obsessions in patients with recent onset schizophrenia and other psychotic disorders. J Clin Psychiatry. 1999; 60(6): 364-365. (Pubitemid 29289722)
18. Ertugrul A, Anil Yagcioglu AE, Eni N, Yazici KM. Obsessivecompulsive symptoms in clozapine-treated schizophrenic patients. Psychiatry Clin Neurosci. 2005; 59(2): 219-222. (Pubitemid 40524961)
19. Mahendra R, Liew E, Subramaniam M. De novo emergence of obsessive-compulsive symptoms with atypical antipsychotics in asian patients with schizophrenia or schizoaffective disorder: a retrospective, cross-sectional study. J Clin Psychiatry. 2007; 68(4): 542-545. (Pubitemid 46663036)
20. Sa AR, Hounie AG, Sampaio AS, et al. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol. Compr Psychiatry. 2009; 50(5): 437-442.
21. deHaan L, Oekeneva A, Van Amelsvoort T, Linszen D. Obsessivecompulsive disorder and treatment with clozapine in 200 patients with recent-onset schizophrenia or related disorders. Eur Psychiatry. 2004; 19(8): 524. (Pubitemid 39602782)
22. Poyurovsky M, Weizman A, Weizman R. Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment. CNS Drugs. 2004; 18(14): 989-1010. (Pubitemid 39612010)
23. Schirmbeck F, Esslinger C, Rausch F, et al. Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia. Psychol Med. 2011; 41(11): 2361-2373.
24. Schirmbeck F, Rausch F, Englisch S, et al. Differential effects of antipsychotics agents on obsessive-compulsive symptoms in schizophrenia: a longitudinal study. J Psychopharmacol. 2013; 27(4): 349-357.
25. Tanahashi S, Yamamura S, Nakagawa M, Motomura E, Okada M. Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes. Br J Pharmacol. 2012; 165(5): 1543-1555.
26. Pallanti S, Grassi G, Cantisani A. Approaches to treatment resistance. In: Zohar J, ed. Obsessive-Compulsive Disorder: Current Science and Clinical Practice. Hoboken, NJ: John Wiley & Sons; 2012; 99-134.
27. Kwon JS, Joo YH, Nam HJ, et al. Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms. Arch Gen Psychiatry. 2009; 66(11): 1233-1241.
28. Schirmbeck F, Nieratschker V, Frank J, et al. Polymorphisms in the glutamate transporter gene SLC1A1 and obsessive-compulsive symptoms induced by second-generation antipsychotic agents. Psychiatr Genet. 2012; 22(5): 245-252.
29. Cai J, Zhang W, Yi Z, et al. Influence of polymorphism in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessivecompulsive symptoms. Psychopharmacology (Berl). 230(1): 49-55.
30. Poyurovsky M, Fuchs C, Faragian S, et al. Preferential aggregation of obsessive-compulsive spectrum disorders in schizophrenia patients with obsessive-compulsive disorder. Can J Psychiatry. 2006; 51(12): 746-754. (Pubitemid 44656505)
31. Bienvenu OJ, Samuels JF, Wuliek LA, et al. Is obsessive-compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective. Psychol Med. 2012; 42(1): 1-13.
32. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, text rev. Washington, DC: American Psychiatric Association; 2000.
33. First MB, Spritzer RL, Gibbon M, Willians JBW. Structured Clinical Interview for DSM-IVAxis I Disorders. Patient Edition (Version 2.0). Biometric Research Department. New York: New York State Psychiatric Institute; 1995.
34. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987; 13(2): 261-276. (Pubitemid 18039085)
35. Montogomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979; 134(4): 382-389. (Pubitemid 9136500)
36. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959; 32(1): 50-55.
37. Goodman W, Price L, Rasmussen S, et al. The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), part I: development, use, and reliability. Arch Gen Psychiatry. 1989; 46: 1006-1011. (Pubitemid 19278229)
38. Goodman W, Price L, Rasmussen S, et al. The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), part II: validity. Arch Gen Psychiatry. 1989; 46(11): 1012-1016. (Pubitemid 19278230)
39. Greeven A, Spinhoven P, van Balkom AJ. Hypochondriasis Y-BOCS: a study of the psychometric properties of a clinician-administered semi-structured interview to assess hypochondriacal thoughts and behaviours. Clin Psychol Psychother. 2009; 16(5): 431-443.
40. Hall RC. Global assessment of functioning: a modified scale. Psychosomatics. 1995; 36(3): 267-275.
41. Starcevic V. Hypochondriasis and health anxiety: conceptual challenges. Br J Psychiatry. 2013; 202(1): 7-8.
42. Hiller W, Fichter MM. High utilizers of medical care: a crucial subgroup among somatizing patients. J Psychosom Res. 2004; 56(4): 437-443. (Pubitemid 38490733)
43. deHaan L, Beuk N, Hoogenboom B, Dingemans P, Linszen D. Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recentonset schizophrenia or related disorders. J Clin Psychiatry. 2002; 63(2): 104-107. (Pubitemid 34173845)